1375069-06-9 Usage
Uses
Used in Organic Synthesis:
2-Bromo-6-fluoro-3-methylbenzyl alcohol is used as a building block in organic synthesis for its ability to participate in a variety of chemical reactions due to the presence of bromine, fluorine, and methyl groups. This makes it a versatile intermediate for the creation of more complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Bromo-6-fluoro-3-methylbenzyl alcohol is used as a key intermediate in the development of new drugs. Its unique functional groups allow for the design of molecules with specific biological activities, potentially leading to the discovery of novel therapeutic agents.
Used in Chemical Research:
2-Bromo-6-fluoro-3-methylbenzyl alcohol is utilized as a research compound in academic and industrial laboratories. Its distinct properties make it suitable for studying reaction mechanisms, exploring the effects of functional group substitutions, and advancing the understanding of organic chemistry.
Used in Specialty Chemicals Production:
2-BroMo-6-fluoro-3-Methylbenzyl alcohol is also used in the production of specialty chemicals where its specific functional groups can impart unique properties to the final products, such as enhanced solubility, reactivity, or stability.
Each application takes advantage of the compound's distinctive structural features, highlighting its importance in the fields of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1375069-06-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,0,6 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1375069-06:
(9*1)+(8*3)+(7*7)+(6*5)+(5*0)+(4*6)+(3*9)+(2*0)+(1*6)=169
169 % 10 = 9
So 1375069-06-9 is a valid CAS Registry Number.
1375069-06-9Relevant articles and documents
INHIBITING HUMAN INTEGRIN α4β7
-
, (2021/04/23)
Disclosed are small molecule antagonists of human α4β7 integrin, and methods of using them to treat a number of diseases and conditions.
Phenethyl nicotinamides, a novel class of NaV1.7 channel blockers: Structure and activity relationship
Kers, Inger,MacSari, Istvan,Csjernyik, Gabor,Nyloef, Martin,Skogholm, Karin,Sandberg, Lars,Minidis, Alexander,Bueters, Tjerk,Malmborg, Jonas,Eriksson, Anders B.,Lund, Per-Eric,Venyike, Elisabet,Luo, Lei,Nystroem, Jan-Erik,Besidski, Yevgeni
, p. 6108 - 6115 (2012/10/30)
The NaV1.7 ion channel is an attractive target for development of potential analgesic drugs based on strong genetic links between mutations in the gene coding for the channel protein and inheritable pain conditions. The (S)-N-chroman-3-ylcarboxamide series, exemplified by 1, was used as a starting point for development of new channel blockers, resulting in the phenethyl nicotinamide series. The structure and activity relationship for this series was established and the metabolic issues of early analogues were addressed by appropriate substitutions. Compound 33 displayed acceptable overall in vitro properties and in vivo rat PK profile.
